Variant report
Variant | esv18796 |
---|---|
Chromosome Location | chr1:220503012-220503523 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs184854405 | chr1:220503075-220503076 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs189623354 | chr1:220503102-220503103 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs536638677 | chr1:220503126-220503127 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs564740321 | chr1:220503147-220503148 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs192306877 | chr1:220503155-220503156 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs541772107 | chr1:220503173-220503174 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs377143930 | chr1:220503208-220503209 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs555950903 | chr1:220503216-220503217 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs116152340 | chr1:220503232-220503233 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs541654157 | chr1:220503262-220503263 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs564423038 | chr1:220503291-220503292 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs546066660 | chr1:220503296-220503297 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs184510360 | chr1:220503327-220503328 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs77856389 | chr1:220503333-220503334 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs572847996 | chr1:220503341-220503342 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs138947113 | chr1:220503347-220503348 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs529122113 | chr1:220503398-220503399 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs17641428 | chr1:220503401-220503402 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs74939743 | chr1:220503431-220503432 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs58108315 | chr1:220503452-220503453 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs139925506 | chr1:220503517-220503518 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs61652479 | chr1:220503521-220503522 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 18172304 | CNVD |
Rett syndrome | 21593744 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Cervical cancer | 21063398 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 20632083 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 21264507 | CNVD |
Liposarcoma | 21253554 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Cancer | 16751803 | CNVD |
Prostate cancer | 16705090 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16461572 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Breast cancer | 21858162 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 16608533 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17001317 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Breast cancer | 21509527 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Chordoma | 18071362 | CNVD |
Multiple myeloma | 16461302 | CNVD |
van der Woude syndrome | 22470819 | CNVD |
van der Woude syndrome | 20818247 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Urothelial tumor | 18831757 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Holoprosencephaly | 19184110 | CNVD |
Breast cancer | 21069454 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Mental retardation | 19951919 | CNVD |
Non-syndromic sensorineural hearing loss | 17873649 | CNVD |
Acute myeloid leukemia | 17268525 | CNVD |
Lung cancer | 16740712 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Developmental delay | 21147756 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Autism | 14699429 | CNVD |
Breast cancer | 21364760 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Tetralogy of Fallot | 22912587 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:220499000-220509400 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
2 | chr1:220500600-220510800 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
3 | chr1:220500800-220509000 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
4 | chr1:220501400-220508800 | Weak transcription | Esophagus | oesophagus |
5 | chr1:220502600-220503200 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
6 | chr1:220502600-220504200 | Enhancers | Brain Germinal Matrix | brain |
7 | chr1:220502800-220503200 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
8 | chr1:220502800-220503600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
9 | chr1:220502800-220504200 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
10 | chr1:220502800-220505000 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
11 | chr1:220503000-220505000 | Enhancers | Cortex derived primary cultured neurospheres | brain |
12 | chr1:220503200-220503400 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
13 | chr1:220503200-220510600 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
14 | chr1:220503400-220503800 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
15 | chr1:220503400-220509000 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |